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Previous images show the 2D dose maps obtained with the GEM 
detector in 64 seconds. On the right there is the map for a 2,4 x 2,4 
cm X-rays irradiation field, on the left the one for a 4,0 x 4,0 cm X-
rays irradiation field. 
Conclusions: Our detector could represent significant improvement 
compared to measurement systems used until today. The results 
confirm its potentialities especially in terms of spatial resolution, 
acquisition time and linearity.  
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Purpose/Objective: Two-dimensional (2D) array detector has finite 
resolution due to its detector size and spacing. Dosimetric verification 
of small targets planned with IMRT is difficult because of the limited 
resolution as only a limited number of pixels handling the fluence. In 
addition, the overall inaccuracy due to the interpolation of signals will 
be higher. However, if the small field IMRT is verified at extended 
source to surface distance (SSD), fluence can be handled by the large 
area of the array and hence the more number of detectors due to 
inverse square law. Therefore, the purpose of the present study is to 
evaluate the response of 2D-detector array at extended SSDs for pre-
treatment verification of small targets. 
Materials and Methods: Four previously treated patients were 
studied. In planning CT slices, planning target volume (PTV) and organ 
at risk (OAR) were contoured. IMRT (sliding window) plans were 
generated in Eclipse (Varian Medical Systems, Palo Alto, CA, USA) 
treatment planning system (TPS) for Varian CL2300C/D linear 
accelerator using 5-7 fields of 6MV photon beam. For each patient, 
four verification plans were generated at 95cm, 100cm, 105cm and 
110cm SSD by keeping I’matriXX at 5cm depth. The planned fluence 
was then transferred to previously scanned I’matriXX (IBADosimetry, 
Scanditronix Wellhofer, Germany) and solid water slab assembly and 
doses were calculated. The dose planes measured with I’matriXX were 
compared with TPS calculated dose planes at corresponding SSD in 
OmniPro-IMRT software using 2D gamma (γ) index analysis. For gamma 
index analysis, 3% dose difference and 3mm distance to agreement 
criteria (3%/3mm) was used. Three parameters i.e. gamma maximum 
(γmax.), gamma average (γavg.)and percentage of pixels passing gamma 
value up to 1 (γ% ≤1) were noted. 
Results: 
Results are summarized in table-1. 
 
Table-1 shows the γ index analysis results for four patients 
 
 
 Patient-1 Patient-2 
SSD (cm) 95 100 105 110 95 100 105 110 
γ% ≤1 99.73 99.92 99.98 99.97 99.84 99.93 99.85 99.94 
γmax. 1.57 1.25 1.14 1.18 1.47 1.33 1.42 1.36 
γavg. 0.07 0.07 0.08 0.09 0.03 0.03 0.04 0.04 
 Patient-3 Patient-4 
SSD (cm) 95 100 105 110 95 100 105 110 
γ%≤1 99.25 99.63 99.48 99.58 99.55 99.78 99.90 99.87 
γmax. 1.68 1.51 1.61 1.73 1.95 1.77 1.37 1.48 
γavg. 0.08 0.07 0.08 0.07 0.05 0.05 0.05 0.06 
 
Figure-1 shows the increase in measurement area with increase in SSD 
from 95-110cm 
 
 
Conclusions: The verification of small IMRT fields showed increased 
gamma pass rate when measured at extended SSDs compared to the 
verification at normal measurement distance. This may be attributed 
to the involvement of increased number pixel chambers at larger SSD 
which increased the resolution and accuracy of measured dose-plane.  
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Purpose/Objective: To investigate the properties and efficacy of 
ArcCHECK (Sun Nuclear Corp., Melbourne, FL) in quality assurance 
(QA) of Helical TomoTherapy treatment delivery. 
Materials and Methods: Nine clinical Helical TomoTherapy plans of 
different treatment regions and beam widths were randomly selected 
for dosimetric QA measurement using ArcCHECK. A series of test plans 
with cylindrical targets of different dimensions and with different 
treatment beam widths were also made for testing the performance 
of ArcCHECK. Fine grid was used for all test plan optimisation and 
dose calculation. Gamma analysis (passing criteria: 3 % dose 
